Mini-Sentinel and Regulatory Science — Big Data Rendered Fit and Functional von Psaty, Bruce M, Breckenridge, Alasdair M

Volltext

Report on the current status of the use of real‐world data (RWD) and real‐world evidence (RWE) in drug development and regulation von Breckenridge, Alasdair M., Breckenridge, Ross A., Peck, Carl C.

Volltext

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients von Pirmohamed, Munir, James, Sally, Meakin, Shaun, Green, Chris, Scott, Andrew K, Walley, Thomas J, Farrar, Keith, Park, B Kevin, Breckenridge, Alasdair M

Volltext

Open clinical trial data for all? A view from regulators von Eichler, Hans-Georg, Abadie, Eric, Breckenridge, Alasdair, Leufkens, Hubert, Rasi, Guido

Volltext

New approaches to drug safety: a pharmacovigilance tool kit von Raine, June, Breckenridge, Alasdair, Wise, Lesley, Parkinson, John

Volltext

Precision medicine and the changing role of regulatory agencies von Breckenridge, Alasdair, Eichler, Hans-Georg, Jarow, Jonathan P.

Volltext

Regulatory Frameworks in Times of Uncertainty von Breckenridge, Alasdair

Volltext

Observations on Three Endpoint Properties and Their Relationship to Regulatory Outcomes of European Oncology Marketing Applications von Liberti, Lawrence, Stolk, Pieter, McAuslane, James Neil, Schellens, Jan, Breckenridge, Alasdair M., Leufkens, Hubert

Volltext

Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled tria... von Aponte, John J, MD, Schellenberg, David, Prof, Egan, Andrea, PhD, Breckenridge, Alasdair, MD, Carneiro, Ilona, PhD, Critchley, Julia, PhD, Danquah, Ina, MPhil, Dodoo, Alexander, PhD, Kobbe, Robin, MD, Lell, Bertrand, MD, May, Jürgen, MD, Premji, Zul, MD, Sanz, Sergi, PhD, Sevene, Esperanza, MD, Soulaymani-Becheikh, Rachida, MD, Winstanley, Peter, MD, Adjei, Samuel, MD, Anemana, Sylvester, MD, Chandramohan, Daniel, MD, Issifou, Saadou, MD, Mockenhaupt, Frank, MD, Owusu-Agyei, Seth, MD, Greenwood, Brian, Prof, Grobusch, Martin P, Prof, Kremsner, Peter G, Prof, Macete, Eusebio, MD, Mshinda, Hassan, MD, Newman, Robert D, MD, Slutsker, Laurence, MD, Tanner, Marcel, Prof, Dr, Alonso, Pedro, Prof, Menendez, Clara, MD

Volltext

Overcoming the legal and regulatory barriers to drug repurposing von Breckenridge, Alasdair, Jacob, Robin

Volltext

A Proposed Framework for a Globally Applicable Pragmatic Approach to Using Facilitated Regulatory Pathways von Liberti, Lawrence, McAuslane, Neil, Stolk, Pieter, Breckenridge, Alasdair, Leufkens, Hubert

Volltext

Impact of Brexit on UK and EU Drug Regulation and Patient Access von Breckenridge, Alasdair, Feldschreiber, Peter

Volltext

The burden of adverse drug events von Breckenridge, Alasdair

Volltext

Response to “Medicines Shortages in the United Kingdom” von Breckenridge, Alasdair, Feldschreiber, Peter

Volltext

Accelerated approval of medicines: fit for purpose? von Breckenridge, Alasdair, Liberti, Lawrence

Volltext

Commentary on 'Transparency and Trust in the European Pharmaceutical Sector' von Breckenridge, Alasdair

Volltext

Therapy of Falciparum Malaria in Sub-Saharan Africa: from Molecule to Policy von WINSTANLEY, Peter, WARD, Stephen, SNOW, Robert, BRECKENRIDGEL, Alasdair

Volltext

SIR DAVID JACK: 22 February 1924 — 8 November 2011 von Breckenridge, Alasdair

Volltext

Development and delivery of clinical pharmacology in regulatory agencies von Breckenridge, Alasdair

Volltext

Prof. John Urquhart von Breckenridge, Alasdair, Hughes, Dyfrig

Volltext